期刊文献+

徐州市559株结核分枝杆菌耐药性分析

Analysis of 559 mycobacterium tuberculosis resistant to anti-tuberculosis drug in Xuzhou
原文传递
导出
摘要 目的:研究徐州市肺结核病人耐药情况。方法:用改良酸性罗氏培养基对徐州市559例肺结核病人进行痰培养,再对菌株进行菌型鉴定和药物敏感性试验。结果:对4种药物都敏感的占62.79%。对1种或1种以上药物耐药的占37.21%。对1种药的耐药率分别为:H-28.09%(157/559),S-26.83%(150/559),R-21.82%(122/559),E-12.34%(69/559)。我市肺结核病人总体耐多药率为16.63%,其中初治患者耐多药率为2.08%,复治患者耐多药率为32.10%。结论:我市结核病人耐药率仍处于较高水平,一线药对肺结核病人没有良好治疗效果,初治病人和复治病人耐药率差别有显著性。 Objective:To study the status of anti-tuberculosis drug resistance in patients with pulmonary tuberculosis in Xuzhou.Methods: The reformed L-J medium was applied to 559 patients with TB to perform sputum culture.The bacterial type was evaluated and drug susceptibility testing was performed.Results: The susceptible rate to four drugs is 62.79%.The resistance to one or more drugs is 37.21%.The resistant rate to one drug are: H-28.09%(157/559),S-26.83%(150/559),R-21.82%(122/559),E-12.34%(69/559).The overall multi-drug resistant rate in our city is 16.63%,and the rate in the primary and re-treated case is 2.08% and 32.10% respectively.Conclusion: The drug resistant rate in our city is still very high.The first-line drugs do not have good result in patients with pulmonary tuberculosis.There is a significant difference between the drug-resistant rate in the primary and re-treated cases.
出处 《中国卫生检验杂志》 CAS 2011年第7期1720-1721,共2页 Chinese Journal of Health Laboratory Technology
基金 国家自然科学基金资助项目(30771853)
关键词 肺结核 结核分枝杆菌 药敏试验 耐多药 Pulmonary tuberculosis Mycobacterium tuberculosis Drug susceptibility testing Multi-drug resistant
  • 相关文献

参考文献5

二级参考文献27

  • 1李桂莲,王撷秀,赵德福.结核分枝杆菌耐药基因的研究进展[J].中国慢性病预防与控制,2006,14(5):377-379. 被引量:17
  • 2陈明亭.我国耐多药肺结核控制工作现状与展望.中国防痨杂志,2007,29(33):34-34.
  • 3Corbett EL,Watt C J,Walker N,et al.The growing burden of tuberculosis:global trends and interactions with the HIV epidemic[J].Arch Intern Med,2003,163 (9):1009-1021.
  • 4Palomino JC,Martin A,Portaels F.Rapid drug resistance detection in mycobacterium tuberculosis:a review of colourimetric methods[J].Clin Microbiol Infect,2007,13 (8):754-762.
  • 5Ahmad S,Mokaddas E.Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis[J].Respir Med,2009,103(12):1777-1790.
  • 6Moore DA,Evans CA,Gilman RH,et al.Microscopic-observation drug-susceptibility assay for the diagnosis of TB[J].N Engl J Med,2006,355 (15):1539-1550.
  • 7Shiferaw G,Woldeamanuel Y,Gebeyehu M,et al.Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant mycobacterium tuberculosis[J].J Clin Microbiol,2007,45 (4):1093-1097.
  • 8Kalantri S,Pai M,Pascopella L,et al.Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens:a systematic review and meta-analysis[J].BMC Infect Dis,2005,5(1):59.
  • 9Baan CC,van der Mast BJ,Klepper M,et al.Differential effect of calcineurin inhibitors,anti-CD25 antibody and rapamycin on the indution of FOXP3 in human T cells[J].Transplantation,2005,80(1):110-117.
  • 10Barry S,Lipman M,Breen R,et al.Local i mmunodiagnosis of pulmonary TB:ELISPOT or flow cytometry,PPD or ESAT-6?[J].Eur Respir J,2008,32 (2):531-532.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部